Form 4: Masimo Director Timothy Scannell Reports RSU Transactions

Director Timothy J. Scannell acquired 1,119 restricted stock units and exercised 1,225 units into common stock.

Summary

• Director Timothy J. Scannell exercised 1,225 restricted stock units (RSUs) into common stock on April 29, 2026.
• The director was granted 1,119 new RSUs on April 23, 2026, at a price of $178.71 per unit.
• Following these transactions, the director holds 2,608 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation activity.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

• None identified.

Risks

• Future value of RSUs is subject to market price fluctuations of Masimo common stock.

Future Outlook

The newly granted RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders.

Management Comments

• None.

Industry Context

StockSavvy.ai notes that routine equity compensation filings for directors are standard corporate governance practices and generally do not signal shifts in company strategy or financial health.

Comparison to Industry Standards

• The use of RSU-based compensation for board members is consistent with standard practices among mid-to-large cap medical technology companies.
• Vesting schedules tied to annual meetings are common in the industry to ensure director retention.

Stakeholder Impact

• Minimal impact on shareholders as these are standard equity compensation disclosures.

Next Steps

• Vesting of the 1,119 RSUs granted on April 23, 2026, expected by April 2027.

Key Dates

Keywords

Masimo, MASI, Insider Trading, Form 4, Restricted Stock Units, Director Ownership